fig1
![Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?](https://image.oaes.cc/4831dfe0-b1c3-4320-bdc6-8e188eec8725/4268.fig.1.jpg)
Figure 1. The proposed interplay between insulin resistance and NAFLD/MAFLD and subsequent development of diabetes, chronic kidney disease, and cardiac disease. NAFLD: Nonalcoholic fatty liver disease; MAFLD: metabolic associated fatty liver disease; ROS: Reactive oxygen species; BUN: blood urea nitrogen; RAAS: renin-angiotensin-aldosterone system; GGT: gamma-glutamyl transferase.